CATALOGO DEI PRODOTTI DELLA RICERCA

BRONTE, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.053
EU - Europa 7.000
AS - Asia 4.839
SA - Sud America 680
AF - Africa 68
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.672
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.963
GB - Regno Unito 2.843
SG - Singapore 2.038
CN - Cina 1.590
IT - Italia 750
HK - Hong Kong 734
BR - Brasile 606
RU - Federazione Russa 603
DE - Germania 598
FI - Finlandia 526
FR - Francia 525
IE - Irlanda 437
SE - Svezia 337
UA - Ucraina 138
VN - Vietnam 114
NL - Olanda 77
KR - Corea 74
TR - Turchia 60
CA - Canada 55
IN - India 44
AT - Austria 36
ID - Indonesia 34
BE - Belgio 29
JP - Giappone 27
ES - Italia 25
AR - Argentina 22
BD - Bangladesh 21
AU - Australia 18
MX - Messico 18
ZA - Sudafrica 18
PL - Polonia 16
EC - Ecuador 15
CZ - Repubblica Ceca 11
PK - Pakistan 11
IQ - Iraq 10
CO - Colombia 9
MA - Marocco 9
SA - Arabia Saudita 9
TG - Togo 9
NZ - Nuova Zelanda 8
VE - Venezuela 8
UZ - Uzbekistan 7
AZ - Azerbaigian 6
CL - Cile 6
EG - Egitto 6
TN - Tunisia 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
BY - Bielorussia 5
OM - Oman 5
AM - Armenia 4
BO - Bolivia 4
IL - Israele 4
IR - Iran 4
JM - Giamaica 4
KE - Kenya 4
LV - Lettonia 4
MY - Malesia 4
PY - Paraguay 4
RO - Romania 4
CH - Svizzera 3
CR - Costa Rica 3
EE - Estonia 3
HU - Ungheria 3
JO - Giordania 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
NG - Nigeria 3
NP - Nepal 3
PE - Perù 3
PH - Filippine 3
AD - Andorra 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
LK - Sri Lanka 2
LT - Lituania 2
MK - Macedonia 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SO - Somalia 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
CG - Congo 1
CU - Cuba 1
CY - Cipro 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GL - Groenlandia 1
Totale 20.651
Salva come PNG Salva come JPEG
Città #
Southend 2.673
Jacksonville 1.243
Singapore 912
Chandler 857
Woodbridge 851
Hong Kong 721
Dallas 670
Ann Arbor 635
Houston 433
Dublin 427
Ashburn 379
Verona 374
Beijing 259
Lawrence 220
Princeton 220
Wilmington 217
Munich 167
Helsinki 133
Nanjing 132
New York 130
The Dalles 126
Los Angeles 122
Shenyang 119
Jinan 115
Sindelfingen 84
Columbus 80
Redmond 75
Buffalo 74
Hebei 66
Tianjin 63
Milan 58
Nanchang 55
Haikou 51
Ningbo 49
San Francisco 48
Hangzhou 46
Zhengzhou 45
Changsha 44
São Paulo 44
Seattle 37
Guangzhou 35
Jiaxing 35
Santa Clara 34
Taizhou 34
Chicago 32
Turku 32
Norwalk 31
Jakarta 29
Brussels 28
Nuremberg 28
Dong Ket 27
Toronto 27
Boardman 25
Taiyuan 25
Amsterdam 23
Council Bluffs 22
Redwood City 22
Brooklyn 21
Dearborn 20
Fuzhou 20
Seoul 20
Dongguan 19
Falls Church 19
Vienna 19
Ho Chi Minh City 18
London 18
Phoenix 18
Tokyo 18
Washington 18
Rio de Janeiro 17
Belo Horizonte 16
Frankfurt am Main 16
Moscow 16
Brasília 15
Grafing 15
Hanoi 15
Stockholm 15
Boston 14
Fairfield 13
Lappeenranta 12
Düsseldorf 11
Lanzhou 11
Warsaw 11
Atlanta 10
Campinas 10
Johannesburg 10
Padova 10
Redondo Beach 10
San Diego 10
Auburn Hills 9
Cambridge 9
Kochi 9
Lomé 9
St Petersburg 9
Auckland 8
Cagliari 8
Madrid 8
Riyadh 8
Detroit 7
Fortaleza 7
Totale 14.119
Salva come PNG Salva come JPEG
Nome #
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 220
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 216
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 204
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 201
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 170
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 166
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes. 163
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 155
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 154
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 153
Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. 148
Deciphering the state of immune silence in fatal COVID-19 patients 145
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 144
Baricitinib restrains the immune dysregulation in patients with severe COVID-19 144
Role of P2z purinergic receptors in ATP-mediated killing of tumor necrosis factor (TNF)-sensitive and TNF-resistant L929 fibroblasts. 143
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 143
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 142
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 141
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 141
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 141
Human Anti Cancer Cytokine Induced Killer Cells and TheirInteraction With the Host Immune System 135
Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. 131
Adoptive immunotherapy of experimental tumors using cytotoxic lymphocytes to carry and deliver toxins 131
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. 128
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 128
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). 127
Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases. 127
Altered macrophage differentiation and immune dysfunction in tumor development. 125
Antigen specificity of immune suppression by myeloid-derived suppressor cells. 125
Antitumor vaccination: where we stand. 124
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. 123
The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment 123
MDSCs in cancer: Conceiving new prognostic and therapeutic targets 123
Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression 121
Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 121
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 121
Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin. 117
Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigen. 116
Adoptive transfer of lymphokine-activated killer cells loaded with 4'-deoxy-4'-iododoxorubicin: therapeutic effect in mice bearing lung metastases. 113
Transcription factors in myeloid-derived suppressor cell recruitment and function. 113
New idrosoluble furoxan derivatives having antitumoral activity 112
Nitric oxide furoxan derivative compounds endowed with antitumoral activity 112
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 111
The Endless Saga of Monocyte Diversity 111
Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model. 110
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. 110
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 110
IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. 109
Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. 109
PDE5 INHIBITOR COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY 108
Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. 107
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages 107
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. 106
Therapeutic targeting of myeloid-derived suppressor cells. 105
Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. 105
Costimulation enhances the active immunotherapy effect of recombinant anticancer vaccines. 104
4PD Functionalized Dendrimers: A Flexible Tool for In Vivo Gene Silencing of Tumor-Educated Myeloid Cells 104
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia 104
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. 103
Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area. 103
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. 103
Detection and functional evaluation of arginase-1 isolated from human PMNs and murine MDSC 102
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment 102
Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. 101
Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c+CD103+Monocytic Antigen-Presenting Cells in Tumors 101
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. 101
Derangement of immune responses by myeloid suppressor cells. 100
mTOR and STAT3 Pathway Hyper-Activation is Associated with evated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment 100
Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation. 99
Meccanismi molecolari della lisi mediata dai linfociti citotossici 99
Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer. 98
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy 97
Gene expression profiling of human fibrocytic myeloid-derived suppressor cells (f-MDSCs) 97
Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes. 97
Smoothing T cell roads to the tumor: Chemokine post-translational regulation. 97
Use of myeloid cell biomarkers for the diagnosis of cancer. 96
Nitric oxide affects immune cells bioenergetics: long-term effects of nitric-oxide derivatives on leukaemic Jurkat cell metabolism 95
Interaction of human pancreatic ductal adenocarcinoma cells with polymeric scaffolds to develop tissue-engineered cancer models. 95
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 94
Role of arginine metabolism in immunity and immunopathology. 94
Role of adhesion molecules in the immune reaction to M-MSV-induced tumors. 94
Resistance of lymphokine-activated T lymphocytes to cell-mediated cytotoxicity. 94
Platelets promote thromboinflammation in SARS-CoV-2 pneumonia 94
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer. 93
Cancer Immune Modulation and Immunosuppressive Cells: Current and Future Therapeutic ApproachesNano-Oncologicals 93
Human fibrocytic myeloid-derived suppressor cells express IDO and promote tolerance via Treg-cell expansion 92
IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. 92
Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. 92
The pros and cons of chemokines in tumor immunology 92
Adipocytes and Neutrophils Give a Helping Hand to Pancreatic Cancers 92
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. 91
IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases. 91
Myeloid-derived suppressor cells generated in vitro 91
Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention. 90
Inhibition of protein tyrosine phosphorylation prevents T-cell-mediated cytotoxicity. 90
Inhibition of CTL-line lysis after gangliosides treatment. 90
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. 89
Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. 89
Extracellular ATP causes lysis of mouse thymocytes and activates a plasma membrane ion channel. 88
Arginase, nitric oxide synthase, and novel inhibitors of L-arginine metabolism 88
Totale 11.649
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.677
article - articoli 71.173
book - libri 0
conference - conferenze 1.529
curatela - curatele 0
other - altro 1.284
patent - brevetti 1.502
selected - selezionate 0
volume - volumi 4.189
Totale 159.354
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.374 0 0 65 188 324 164 23 132 151 37 203 87
2021/20221.735 106 442 31 52 74 47 70 111 115 89 151 447
2022/20232.728 257 262 303 445 230 632 42 154 294 14 57 38
2023/20241.516 63 98 101 192 209 236 66 140 16 87 239 69
2024/20254.793 275 271 146 710 273 163 330 306 828 281 354 856
2025/20262.159 995 635 529 0 0 0 0 0 0 0 0 0
Totale 20.920